Journal article
Evolutionary history of human colitis-associated colorectal cancer
- Abstract:
- Objective IBD confers an increased lifetime risk of developing colorectal cancer (CRC), and colitis-associated CRC (CA-CRC) is molecularly distinct from sporadic CRC (S-CRC). Here we have dissected the evolutionary history of CA-CRC using multiregion sequencing. Design Exome sequencing was performed on fresh-frozen multiple regions of carcinoma, adjacent non-cancerous mucosa and blood from 12 patients with CA-CRC (n=55 exomes), and key variants were validated with orthogonal methods. Genome-wide copy number profiling was performed using single nucleotide polymorphism arrays and low-pass whole genome sequencing on archival non-dysplastic mucosa (n=9), low-grade dysplasia (LGD; n=30), high-grade dysplasia (HGD; n=13), mixed LGD/HGD (n=7) and CA-CRC (n=19). Phylogenetic trees were reconstructed, and evolutionary analysis used to reveal the temporal sequence of events leading to CA-CRC. Results 10/12 tumours were microsatellite stable with a median mutation burden of 3.0 single nucleotide alterations (SNA) per Mb, ~20% higher than S-CRC (2.5 SNAs/Mb), and consistent with elevated ageing-associated mutational processes. Non-dysplastic mucosa had considerable mutation burden (median 47 SNAs), including mutations shared with the neighbouring CA-CRC, indicating a precancer mutational field. CA-CRCs were often near triploid (40%) or near tetraploid (20%) and phylogenetic analysis revealed that copy number alterations (CNAs) began to accrue in non-dysplastic bowel, but the LGD/HGD transition often involved a punctuated ‘catastrophic’ CNA increase. Conclusions Evolutionary genomic analysis revealed precancer clones bearing extensive SNAs and CNAs, with progression to cancer involving a dramatic accrual of CNAs at HGD. Detection of the cancerised field is an encouraging prospect for surveillance, but punctuated evolution may limit the window for early detection.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 5.9MB, Terms of use)
-
- Publisher copy:
- 10.1136/gutjnl-2018-316191
Authors
+ Crohn’s and Colitis UK
More from this funder
- Funding agency for:
- Leedham, S
- Graham, T
- Grant:
- M/15/5
- M/15/5
+ National Institute for Health Research
More from this funder
- Funding agency for:
- East, J
- Leedham, S
- Grant:
- M/15/5
+ Derek Willoughby Fund for Inflammatory Research
More from this funder
- Funding agency for:
- Choi, C
- Hart, A
- Graham, T
- Grant:
- M/15/5
+ Medical Research Council
More from this funder
- Funding agency for:
- Choi, C
- Hart, A
- Graham, T
- Grant:
- M/15/5
+ Cancer Research UK
More from this funder
- Funding agency for:
- Baker, A
- Wright, N
- Leedham, S
- Graham, T
- Grant:
- A14895
- A14895
- M/15/5
- M/15/5
- Publisher:
- BMJ Publishing Group
- Journal:
- Gut More from this journal
- Volume:
- 68
- Issue:
- 6
- Pages:
- 985-995
- Publication date:
- 2018-07-10
- Acceptance date:
- 2018-06-02
- DOI:
- EISSN:
-
1468-3288
- ISSN:
-
0017-5749
- Pubs id:
-
pubs:854833
- UUID:
-
uuid:29fd8019-0b3b-4da0-9404-bd39c4b453dd
- Local pid:
-
pubs:854833
- Source identifiers:
-
854833
- Deposit date:
-
2018-06-04
Terms of use
- Copyright holder:
- Baker, et al
- Copyright date:
- 2018
- Notes:
- This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record